
MODERNA, INC.
MRNA
![]() |
|
122.87USD | -1.71% |
Turn to zoom
Prev. | 125.0100 |
Open | 124.5100 |
High | 126.0101 |
Low | 122.3500 |
Volume | 16 528 897 |
Latest news
Chart MODERNA, INC.
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Bearish | Bullish | Bullish |
Resistance | 137 | 170 | 157 |
Spread/Res. | -10% | -28% | -22% |
Spread/Supp. | 18% | 26% | 144% |
Support | 104 | 98,0 | 50,5 |
Financials
|
|
Company
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:
- Collaboration revenue (79.8%);
- Grant revenue (20.2%).
At the end...
>> Read more
- Collaboration revenue (79.8%);
- Grant revenue (20.2%).
At the end...
>> Read more
Sector : |
Biotechnology & Medical Research - NEC
|
Calendar : |
2021-03-10 Earnings Release
|
Trading Rating : |
Investor Rating : |
Income Statement Evolution
Consensus
Mean consensus | OUTPERFORM |
Number of Analysts | 16 |
Average target price | 136,60 $ |
Last Close Price | 125,01 $ |
Spread / Highest target | 48,0% |
Spread / Average Target | 9,27% |
Spread / Lowest Target | -44,8% |